| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |